Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of cefazolin (a first-generation cephalosporin antibiotic) and indomethacin (a non-steroidal anti-inflammatory drug) used perioperatively during physical examination-indicated cerclage placement in pregnant women. This combination has been shown to significantly prolong gestational latency without increasing the incidence of chorioamnionitis. The standard protocol involves weight-based intravenous cefazolin (1g if <100kg, 2g if >100kg) pre-operatively and every 8 hours for two doses post-operatively, along with 50mg indomethacin orally immediately post-operatively, then every 8 hours for two additional doses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cefazolin + indomethacin.